Boxer Capital as of Dec. 31, 2023
Portfolio Holdings for Boxer Capital
Boxer Capital holds 52 positions in its portfolio as reported in the December 2023 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Mirati Therapeutics | 9.4 | $188M | 3.2M | 58.75 | |
Cytokinetics Com New (CYTK) | 8.7 | $175M | 2.1M | 83.49 | |
Springworks Therapeutics (SWTX) | 6.2 | $125M | 3.4M | 36.50 | |
Revolution Medicines (RVMD) | 6.1 | $123M | 4.3M | 28.68 | |
Apellis Pharmaceuticals (APLS) | 5.1 | $103M | 1.7M | 59.86 | |
BeiGene Sponsored Adr | 4.5 | $90M | 500k | 180.36 | |
Tyra Biosciences (TYRA) | 4.5 | $89M | 6.4M | 13.85 | |
ImmunoGen | 4.4 | $88M | 3.0M | 29.65 | |
Nuvalent Inc-a (NUVL) | 4.1 | $82M | 1.1M | 73.59 | |
Tango Therapeutics (TNGX) | 4.0 | $81M | 8.2M | 9.90 | |
Karuna Therapeutics Ord | 3.9 | $79M | 250k | 316.51 | |
Ideaya Biosciences (IDYA) | 3.9 | $78M | 2.2M | 35.58 | |
Sarepta Therapeutics (SRPT) | 3.1 | $63M | 650k | 96.43 | |
Argenx SE Sponsored Adr (ARGX) | 3.0 | $61M | 160k | 380.43 | |
Merus N V (MRUS) | 2.6 | $52M | 1.9M | 27.50 | |
Rocket Pharmaceuticals (RCKT) | 2.2 | $44M | 1.5M | 29.97 | |
Immunovant (IMVT) | 2.1 | $42M | 1.0M | 42.13 | |
Akero Therapeutics (AKRO) | 2.0 | $39M | 1.7M | 23.35 | |
Legend Biotech Corp Sponsored Ads (LEGN) | 1.8 | $36M | 600k | 60.17 | |
Axsome Therapeutics (AXSM) | 1.6 | $32M | 400k | 79.59 | |
Arcus Biosciences Incorporated (RCUS) | 1.5 | $31M | 1.6M | 19.10 | |
Anaptysbio Inc Common (ANAB) | 1.4 | $28M | 1.3M | 21.42 | |
Xenon Pharmaceuticals (XENE) | 1.4 | $28M | 600k | 46.06 | |
Arvinas Ord (ARVN) | 1.2 | $25M | 609k | 41.16 | |
Prothena Corp SHS (PRTA) | 1.2 | $24M | 665k | 36.34 | |
Kalvista Pharmaceuticals (KALV) | 1.0 | $20M | 1.7M | 12.25 | |
Relay Therapeutics (RLAY) | 1.0 | $20M | 1.8M | 11.01 | |
Iteos Therapeutics (ITOS) | 1.0 | $20M | 1.8M | 10.95 | |
Day One Biopharmaceuticals I (DAWN) | 0.9 | $17M | 1.2M | 14.60 | |
Structure Therapeutics Sponsored Ads (GPCR) | 0.8 | $16M | 400k | 40.76 | |
Oric Pharmaceuticals (ORIC) | 0.8 | $16M | 1.7M | 9.20 | |
Iovance Biotherapeutics (IOVA) | 0.6 | $11M | 1.4M | 8.13 | |
Prelude Therapeutics (PRLD) | 0.5 | $11M | 2.6M | 4.27 | |
Avidity Biosciences Ord (RNA) | 0.5 | $10M | 1.1M | 9.05 | |
Nkarta (NKTX) | 0.5 | $9.5M | 1.4M | 6.60 | |
Enliven Therapeutics (ELVN) | 0.4 | $8.9M | 646k | 13.84 | |
Third Harmonic Bio (THRD) | 0.4 | $8.2M | 750k | 10.97 | |
Zentalis Pharmaceuticals (ZNTL) | 0.3 | $6.8M | 450k | 15.15 | |
Geron Corporation (GERN) | 0.3 | $6.3M | 3.0M | 2.11 | |
Spyre Therapeutics Com New (SYRE) | 0.3 | $5.4M | 250k | 21.52 | |
Health Sciences Acq Corp 2 (OBIO) | 0.1 | $2.2M | 238k | 9.13 | |
Fate Therapeutics (FATE) | 0.1 | $1.9M | 500k | 3.74 | |
Kodiak Sciences (KOD) | 0.1 | $1.8M | 600k | 3.04 | |
Bioatla (BCAB) | 0.1 | $1.7M | 686k | 2.46 | |
Black Diamond Therapeutics (BDTX) | 0.1 | $1.4M | 506k | 2.81 | |
Rain Therapeutics | 0.1 | $1.4M | 1.2M | 1.20 | |
Milestone Pharmaceuticals (MIST) | 0.0 | $516k | 309k | 1.67 | |
DBV Technologies S A Sponsored Adr | 0.0 | $476k | 500k | 0.95 | |
Protara Therapeutics Com Stk (TARA) | 0.0 | $392k | 209k | 1.88 | |
Atreca Cl A Com (BCEL) | 0.0 | $291k | 2.2M | 0.13 | |
Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.0 | $16k | 267k | 0.06 | |
Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $1.3k | 67k | 0.02 |